当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析

我武生物

(300357)

  

流通市值:164.39亿  总市值:177.81亿
流通股本:4.84亿   总股本:5.24亿

我武生物(300357)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.35亿元,每股收益0.66元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益273123.25万元,未分配利润171321.24万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产289321.39万元,负债16198.13万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入853,360,357.81484,236,510.36228,471,779.62925,394,524.96
营业总成本459,695,071.95288,042,152.3144,752,871.67578,606,136.89
其他经营收益
营业利润397,697,295.47201,360,980.0984,803,969.06369,109,991.74
利润总额394,278,352.77199,529,092.883,959,420.29365,061,772.89
净利润335,236,989.97170,429,226.3371,551,023.5304,338,394.93
每股收益
其他综合收益-4,046.55-4,365.07-998.016,304.55
综合收益总额335,232,943.42170,424,861.2671,550,025.49304,344,699.48
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,772,325,445.941,683,562,028.461,610,271,076.531,651,487,813.7
非流动资产:
非流动资产合计1,120,888,431.31,106,515,013.981,065,237,218.751,057,637,120.5
资产总计2,893,213,877.242,790,077,042.442,675,508,295.282,709,124,934.2
流动负债:
流动负债合计119,952,859.31180,196,275.9584,486,047.67182,583,159.67
非流动负债:
非流动负债合计42,028,479.1643,456,309.8860,642,546.7767,712,099.18
负债合计161,981,338.47223,652,585.83145,128,594.44250,295,258.85
所有者权益(或股东权益):
归属于母公司股东权益合计2,635,739,108.732,467,880,978.572,428,047,771.142,353,706,702.01
股东权益合计2,731,232,538.772,566,424,456.612,530,379,700.842,458,829,675.35
负债和股东权益合计2,893,213,877.242,790,077,042.442,675,508,295.282,709,124,934.2
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计870,623,729.48529,161,653.65261,647,020.63914,531,283.05
经营活动现金流出小计583,732,651.97328,645,801.55175,763,351.98652,091,277.83
经营活动产生的现金流量净额286,891,077.51200,515,852.185,883,668.65262,440,005.22
投资活动产生的现金流量:
投资活动现金流入小计744,697,126.87453,032,942.81351,992,400.12216,559,083.85
投资活动现金流出小计894,953,324.95587,133,109.04339,407,216.58812,154,239.41
投资活动产生的现金流量净额-150,256,198.08-134,100,166.2312,585,183.54-595,595,155.56
筹资活动产生的现金流量:
筹资活动现金流入小计20,000,00015,000,00015,000,0002,775,191.33
筹资活动现金流出小计147,817,678.5378,482,286.3576,466,355.72149,355,114.79
筹资活动产生的现金流量净额-127,817,678.53-63,482,286.35-61,466,355.72-146,579,923.46
汇率变动对现金及现金等价物的影响-4,046.21-4,641.7-1,126.247,802.61
现金及现金等价物净增加额8,813,154.692,928,757.8237,001,370.23-479,727,271.19
期末现金及现金等价物余额106,675,441.5100,791,044.63134,863,657.0497,862,286.81
补充资料:
现金及现金等价物的净增加额-2,928,757.82--479,727,271.19
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券东楠,孙媛媛,黄翰漾0.770.921.112025-10-28
西南证券杜向阳0.740.891.082025-10-25
中泰证券祝嘉琦0.780.941.152025-10-25
申万宏源仰佳佳0.780.951.132025-10-24
国海证券赵宁宁0.730.871.112025-08-31
TOP↑